RTA‐408 protects against propofol‐induced cognitive impairment in neonatal mice via the activation of Nrf2 and the inhibition of NF‐κB p65 nuclear translocation
Abstract Objective To explore the effect of RTA‐408 on the propofol‐induced cognitive impairment of neonatal mice via regulating Nrf2 and NF‐κB p65 nuclear translocation. Methods C57BL/6 neonatal mice were randomized into intralipid, propofol, vehicle + propofol, and RTA‐408 + propofol groups. The l...
Main Authors: | Ling Zhang, Qian Zhou, Chun‐Li Zhou |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-01-01
|
Series: | Brain and Behavior |
Subjects: | |
Online Access: | https://doi.org/10.1002/brb3.1918 |
Similar Items
-
The novel triterpenoid RTA 408 protects human retinal pigment epithelial cells against H2O2-induced cell injury via NF-E2-related factor 2 (Nrf2) activation
by: Xiaobin Liu, et al.
Published: (2016-08-01) -
Variable effects of omaveloxolone (RTA408) on primary fibroblasts with mitochondrial defects
by: Madleen Zighan, et al.
Published: (2022-08-01) -
Nrf2 Activation Protects Against Organic Dust and Hydrogen Sulfide Exposure Induced Epithelial Barrier Loss and K. pneumoniae Invasion
by: Denusha Shrestha, et al.
Published: (2022-04-01) -
FDA Approves Omaveloxolone based on Successful Moxie Trial Results for Friedreich's Ataxia - Review
by: Krzysztof Kania, et al.
Published: (2023-08-01) -
NRF2 activation suppresses motor neuron ferroptosis induced by the SOD1G93A mutation and exerts neuroprotection in amyotrophic lateral sclerosis
by: Biying Yang, et al.
Published: (2023-08-01)